Brief: Oncoarendi And Galapagos Enter Into Exclusive Collaboration On Chitinase Inhibitors In Fibrosis
05/11/2020 22:09
Nov 5 (Reuters) - Galapagos NV GLPG.AS :
* ONCOARENDI AND GALAPAGOS ENTER INTO EXCLUSIVE
COLLABORATION ON
CHITINASE INHIBITORS IN FIBROSIS
Source text for Eikon: ID:nGNX38FJ77
Further company coverage: GLPG.AS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments